GO:0003189 aortic valve formation: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003189 aortic valve formation describes the developmental process that builds the initial aortic valve structure from unspecified precursor tissues, ending when the structural rudiment becomes recognizable.
• The process depends on tightly regulated signaling, including Notch, ERK1/2, JNK, NF-kB, and oxidative-stress-responsive pathways that influence valve cell differentiation and extracellular matrix remodeling.
• Dysregulation of aortic valve formation and subsequent valve cell biology contributes to calcific aortic valve disease and bicuspid aortic valve disease, two major clinical entities.
• Key genes implicated in aortic valve development and disease include RUNX2, FOXO1, SMURF2, DUSP26, DPP4, MDM2, LRp5, Notch pathway components, AMBP, FHL3, PALMD, and FOXS1.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate genes in aortic valve formation and calcification.
• Research methods such as RNA-seq, proteomics, and histological imaging are used to map the molecular events of aortic valve formation and to identify therapeutic targets.
Description
Aortic valve formation (GO:0003189) is the developmental process that establishes the initial structure of the aortic valve from unspecified precursor tissues. This process begins with the specific cellular events that contribute to the appearance of the discrete valve structure and ends when the structural rudiment becomes recognizable. Understanding this process is essential because defects in early valve development can lead to congenital valve malformations and predispose individuals to calcific aortic valve disease later in life. The aortic valve is a critical component of the heart, ensuring unidirectional blood flow from the left ventricle to the aorta, and its proper formation requires precise coordination of signaling pathways, transcription factors, and extracellular matrix remodeling. Research into aortic valve formation has revealed that oxidative stress, inflammatory signaling, and metabolic dysregulation can disrupt normal valve development and contribute to disease progression. For example, oxidized LDL and inflammatory mediators can drive valve interstitial cell calcification, a process that mirrors developmental signaling abnormalities. Consequently, studying the molecular mechanisms of aortic valve formation provides insight into both normal development and the pathogenesis of valve disease, offering potential targets for therapeutic intervention.
aortic valve formation At A Glance
| GO ID | GO:0003189 |
|---|---|
| GO term | aortic valve formation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Initial formation of the aortic valve from unspecified precursor tissues |
| Process begins | Specific processes that contribute to the appearance of the discrete structure |
| Process ends | When the structural rudiment is recognizable |
| Related diseases | Calcific aortic valve disease, bicuspid aortic valve disease |
| Key signaling pathways | Notch, ERK1/2, JNK, NF-kB, oxidative stress response |
What Is GO:0003189?
GO:0003189 aortic valve formation is defined as the developmental process pertaining to the initial formation of the aortic valve from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. In other words, it encompasses the early steps of valve morphogenesis, including the specification of valve precursor cells, their proliferation and migration, and the initial deposition of extracellular matrix that shapes the primitive valve structure. This term is a biological process and does not include later stages of valve maturation or remodeling, which are covered by other GO terms.
Why Is aortic valve formation Important in Cell Biology?
Aortic valve formation is critically important because it establishes the structural foundation for a valve that must function continuously for a lifetime. Disruptions in this developmental process can result in congenital valve defects, such as bicuspid aortic valve, which affects approximately 1-2% of the population and is a major risk factor for calcific aortic valve disease. Moreover, molecular pathways that are active during valve formation can be reactivated or dysregulated in adult valve disease, contributing to calcification and stenosis. Understanding the genes and signaling networks that control aortic valve formation therefore has direct clinical relevance for diagnosing, preventing, and treating valve disorders.
• Aortic valve formation is essential for normal heart development and function.
• Defects in this process can lead to congenital bicuspid aortic valve, a common congenital anomaly.
• Dysregulation of developmental pathways contributes to calcific aortic valve disease, the most common valve disorder in adults.
• Oxidative stress and inflammatory signaling during valve formation influence long-term valve health.
• Key genes such as RUNX2, FOXO1, and SMURF2 link developmental mechanisms to valve calcification.
• Notch signaling activation can reverse calcification of aortic valve cells, highlighting developmental pathway plasticity.
• Metabolic regulators like PALMD and AMBP modulate valve cell phenotype and calcification.
• Understanding aortic valve formation aids in identifying therapeutic targets for valve disease.
• CRISPR models enable functional validation of candidate genes in valve development.
• Research on aortic valve formation bridges developmental biology and adult cardiovascular disease.
What Happens During aortic valve formation?
Specification of valve precursor cells
In simple terms: The heart tube first needs to designate which cells will become the aortic valve.
During early heart development, a subset of endocardial and mesenchymal cells becomes specified to form the aortic valve. This specification involves signaling from the myocardium and extracellular matrix cues that activate transcription factors such as RUNX2 and FOXO1, which are later implicated in valve calcification when dysregulated. Oxidative stress and lipid accumulation can influence these early specification events, as oxidized LDL promotes inflammatory signaling that may disrupt normal valve cell fate.
Endothelial-to-mesenchymal transition and cell migration
In simple terms: Some cells change type and move into the valve-forming region to build the valve cushions.
A critical step in aortic valve formation is the endothelial-to-mesenchymal transition (EndMT), where endothelial cells of the outflow tract delaminate and migrate into the underlying extracellular matrix to form the endocardial cushions. This process is regulated by Notch signaling, and activation of Notch via histone acetylation can reverse calcification in aortic valve cells, suggesting that developmental EndMT pathways remain relevant in adult disease. Additionally, DUSP26 and DPP4 have been shown to modulate valve interstitial cell calcification through ubiquitination and inflammatory pathways, which may reflect dysregulation of normal developmental signaling.
Extracellular matrix remodeling and cushion expansion
In simple terms: The valve cushions grow and change their matrix composition to shape the valve.
After EndMT, the endocardial cushions expand through proliferation and deposition of extracellular matrix components such as collagen, elastin, and proteoglycans. This remodeling is influenced by signaling pathways including ERK1/2 and JNK, which are inhibited by AMBP to protect against aortic valve calcification. PALMD regulates glycolysis and NF-kB-mediated inflammation, affecting the metabolic environment that supports cushion expansion. Proper matrix remodeling ensures the structural rudiment becomes recognizable, marking the end of GO:0003189.
Signaling pathways controlling valve morphogenesis
In simple terms: Chemical signals tell the valve cells when to grow, move, and change.
Multiple signaling pathways orchestrate aortic valve formation. Notch signaling is essential for EndMT and valve cell differentiation, and its reactivation can reverse calcification. The ERK1/2 and JNK pathways are modulated by AMBP and FHL3, influencing valve cell calcification. NF-kB signaling, regulated by PALMD, controls inflammation and glycolysis in valve cells. Oxidized LDL and FOXS1 mediate cholesterol transport dysfunction and inflammasome activation, linking lipid metabolism to valve calcification. These pathways collectively ensure proper valve formation and are targets for therapeutic intervention.
Transcriptional regulation of valve development
In simple terms: Master switches in the cell nucleus turn genes on or off to build the valve.
Transcription factors such as RUNX2, FOXO1, and FOXS1 play central roles in aortic valve formation and disease. FOXO1 regulates RUNX2 ubiquitination through SMURF2, affecting calcific aortic valve disease. RUNX2 is a master regulator of osteogenic differentiation and is activated in calcifying valve cells. FOXS1 mediates cholesterol transport dysfunction and inflammasome activation in response to oxidized LDL. These transcriptional networks integrate developmental cues and stress signals to control valve cell fate.
Key Genes Involved in GO:0003189 aortic valve formation
The following genes and proteins have been experimentally implicated in aortic valve formation, valve cell biology, and related calcific valve disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RUNX2 | Master transcription factor for osteogenic differentiation | Regulated by FOXO1/SMURF2 ubiquitination in calcific aortic valve disease |
| FOXO1 | Transcription factor regulating RUNX2 ubiquitination | Modulates SMURF2-mediated RUNX2 degradation in valve calcification |
| SMURF2 | E3 ubiquitin ligase targeting RUNX2 | Mediates FOXO1 effects on RUNX2 stability |
| DUSP26 | Dual-specificity phosphatase | Antagonizes MDM2-mediated ubiquitination of DPP4 in valve calcification |
| DPP4 | Dipeptidyl peptidase 4 | Target of DUSP26 and MDM2 in valvular interstitial cell calcification |
| MDM2 | E3 ubiquitin ligase | Ubiquitinates DPP4; modulated by DUSP26 |
| LRP5 | Wnt co-receptor | Role in oxidative stress and bone formation in bicuspid aortic valve disease |
| Notch pathway components | Cell fate signaling | Activation via histone acetylation reverses valve cell calcification |
| AMBP | Alpha-1-microglobulin/bikunin precursor | Protects against aortic valve calcification by inhibiting ERK1/2 and JNK |
| FHL3 | Four and a half LIM domains protein 3 | Mediates AMBP effects on ERK1/2 and JNK pathways |
| PALMD | Palmdelphin | Regulates glycolysis and NF-kB-mediated inflammation in valve calcification |
| FOXS1 | Forkhead box S1 transcription factor | Mediates oxidized LDL-induced cholesterol transport dysfunction and inflammasome activation |
| sGC | Soluble guanylate cyclase | Oxidized sGC reactivation slows calcific aortic valve stenosis progression |
| NF-kB | Inflammatory transcription factor | Regulated by PALMD in valve calcification |
| ERK1/2 | Mitogen-activated protein kinase | Inhibited by AMBP to protect against calcification |
| JNK | c-Jun N-terminal kinase | Inhibited by AMBP to protect against calcification |
| Inflammasome components | Multiprotein complexes activating inflammation | Activated by FOXS1 in response to oxidized LDL |
How Is aortic valve formation Regulated?
Aortic valve formation is regulated by a complex interplay of signaling pathways and transcriptional networks. Notch signaling is a key regulator of endothelial-to-mesenchymal transition and valve cell differentiation, and its activation via histone acetylation can reverse calcification. The ERK1/2 and JNK pathways are modulated by AMBP and FHL3, with AMBP protecting against calcification by inhibiting these pathways. PALMD regulates glycolysis and NF-kB-mediated inflammation, linking metabolic state to valve cell phenotype. Oxidized LDL and FOXS1 mediate cholesterol transport dysfunction and inflammasome activation, contributing to valve calcification. Additionally, FOXO1 regulates RUNX2 ubiquitination through SMURF2, controlling osteogenic differentiation in valve cells. DUSP26 antagonizes MDM2-mediated ubiquitination of DPP4, influencing valvular interstitial cell calcification. These regulatory mechanisms ensure proper valve formation and, when dysregulated, contribute to disease.
aortic valve formation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RUNX2 | Calcific aortic valve disease | Knockout or point-mutation in valve interstitial cells |
| DUSP26 | Aortic valve calcification | Overexpression and knockout in human valvular interstitial cells |
| LRP5 | Bicuspid aortic valve disease | Knockout mouse models and oxidative stress studies |
| PALMD | Aortic valve calcification | Knockout and overexpression in valve cells |
| FOXS1 | Oxidized LDL-induced valve calcification | Knockout and knock-in models in valve cells |
Calcific aortic valve disease
Calcific aortic valve disease (CAVD) is characterized by progressive thickening and calcification of the aortic valve, leading to stenosis. Molecular pathways active during aortic valve formation, such as Notch, ERK1/2, JNK, and NF-kB signaling, are dysregulated in CAVD. FOXO1 regulates RUNX2 ubiquitination through SMURF2, promoting osteogenic differentiation of valve interstitial cells. DUSP26 antagonizes MDM2-mediated ubiquitination of DPP4, contributing to calcification. Oxidized LDL-induced FOXS1 mediates cholesterol transport dysfunction and inflammasome activation, driving valve calcification. Reactivation of oxidized soluble guanylate cyclase has been shown to slow progression of calcific aortic valve stenosis in preclinical and clinical trials.
Bicuspid aortic valve disease
Bicuspid aortic valve (BAV) is a common congenital anomaly where the aortic valve has two leaflets instead of three. BAV is associated with oxidative stress and altered LRP5-mediated bone formation, which may reflect developmental abnormalities in aortic valve formation. The presence of BAV predisposes individuals to calcific aortic valve disease and other cardiovascular complications, highlighting the clinical importance of understanding early valve developmental processes.
Inflammatory and metabolic contributions to valve disease
Inflammation and metabolic dysregulation are increasingly recognized as drivers of aortic valve disease. PALMD regulates glycolysis and NF-kB-mediated inflammation in valve calcification. AMBP protects against calcification by inhibiting ERK1/2 and JNK pathways mediated by FHL3. These findings suggest that targeting inflammatory and metabolic pathways may offer therapeutic strategies for valve disease.
From aortic valve formation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RUNX2 affect aortic valve formation? | RUNX2 knockout cell model or mouse |
| Does FOXO1 regulation of RUNX2 ubiquitination require SMURF2? | Point mutation of FOXO1 or SMURF2 in valve cells |
| Does DUSP26 antagonize MDM2-mediated DPP4 ubiquitination? | DUSP26 overexpression and knockout in valvular interstitial cells |
| Does Notch activation reverse valve cell calcification? | Knock-in of activated Notch or pharmacological activation |
| Does AMBP protect against calcification via ERK1/2 and JNK? | AMBP overexpression and knockout in valve cells |
| Does PALMD regulate glycolysis and NF-kB in valve calcification? | PALMD knockout and overexpression models |
How to Study the aortic valve formation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identifying pathways in valve formation and disease |
| Proteomics | Protein abundance and modifications | Studying ubiquitination and signaling |
| Immunohistochemistry | Protein localization in tissue | Visualizing valve structure and marker expression |
| Micro-CT | Calcification and valve morphology | Assessing valve calcification in models |
| Alkaline phosphatase assay | Osteogenic differentiation | Evaluating VIC calcification |
| Calcium deposition assay | Calcification extent | Quantifying valve cell calcification |
| Western blot | Protein expression and phosphorylation | Validating signaling changes |
| CRISPR screening | Gene function at scale | Identifying novel regulators of valve formation |
Transcriptomic profiling
RNA sequencing (RNA-seq) is used to identify gene expression changes during aortic valve formation and in valve disease models. For example, studies of PALMD and FOXS1 have utilized transcriptomic approaches to uncover metabolic and inflammatory pathways. RNA-seq can reveal differentially expressed genes and splicing variants that contribute to valve cell phenotype.
Proteomic and ubiquitination analyses
Proteomics and ubiquitination assays are essential to study post-translational modifications in valve cells. FOXO1 regulates RUNX2 ubiquitination through SMURF2, and DUSP26 antagonizes MDM2-mediated ubiquitination of DPP4. These methods identify protein stability networks that control valve calcification.
Histological and imaging techniques
Histological staining, immunohistochemistry, and imaging modalities such as micro-CT are used to visualize valve structure and calcification. Studies of Notch activation and sGC reactivation have employed these techniques to assess valve morphology and calcification in preclinical models.
Functional assays in valve interstitial cells
Valve interstitial cells (VICs) are a primary cell model for studying aortic valve formation and calcification. Assays such as alkaline phosphatase activity, calcium deposition, and gene expression analysis are used to evaluate osteogenic differentiation and calcification in response to genetic manipulations.
How CRISPR Can Be Used to Study GO:0003189 aortic valve formation
Knockout
CRISPR knockout is used to delete candidate genes in valve interstitial cells or animal models to test their requirement for aortic valve formation and calcification. For example, knockout of RUNX2 or FOXO1 can reveal their roles in osteogenic differentiation. Knockout of DUSP26 or PALMD can assess their impact on calcification and inflammation.
Point Mutation
Point mutations can be introduced to model specific amino acid changes that affect protein function, such as those in SMURF2 or FOXO1 that alter ubiquitination of RUNX2. These models help dissect mechanistic details of signaling pathways in valve cells.
Knock-in
Knock-in of tagged or reporter genes allows visualization and tracking of valve cell populations during formation. For example, knocking in a fluorescent reporter under the control of a valve-specific promoter can identify precursor cells. Knock-in of constitutively active Notch can test sufficiency in reversing calcification.
Overexpression
Overexpression of protective genes such as AMBP or dominant-negative constructs can test their ability to prevent calcification. Overexpression of DUSP26 or FOXS1 can mimic disease states and reveal downstream effects.
How EDITGENE Supports aortic valve formation Research
Researchers studying aortic valve formation-related genes often need to determine whether a candidate gene is causally involved in valve development or calcification. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies, from knockout to knock-in and overexpression models, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for aortic valve formation research.
Frequently Asked Questions About aortic valve formation
What is GO:0003189 aortic valve formation?
GO:0003189 is a Gene Ontology biological process term describing the initial formation of the aortic valve from unspecified precursor tissues, ending when the structural rudiment becomes recognizable.
What genes are involved in aortic valve formation?
Key genes include RUNX2, FOXO1, SMURF2, DUSP26, DPP4, MDM2, LRP5, Notch pathway components, AMBP, FHL3, PALMD, and FOXS1.
How is aortic valve formation regulated?
It is regulated by signaling pathways such as Notch, ERK1/2, JNK, NF-kB, and oxidative stress responses, as well as transcription factors like RUNX2 and FOXO1.
What diseases are associated with defects in aortic valve formation?
Defects can lead to bicuspid aortic valve disease and predispose to calcific aortic valve disease.
What research methods are used to study aortic valve formation?
Methods include RNA-seq, proteomics, immunohistochemistry, micro-CT, and functional assays in valve interstitial cells.
How can CRISPR be used to study aortic valve formation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional testing of candidate genes in valve cells.
What is the role of Notch signaling in aortic valve formation?
Notch signaling is essential for endothelial-to-mesenchymal transition and valve cell differentiation, and its activation can reverse calcification.
What is the role of oxidative stress in aortic valve formation?
Oxidative stress, such as from oxidized LDL, can disrupt normal valve cell biology and contribute to calcification through FOXS1 and inflammasome activation.
What cell models are used for aortic valve formation research?
Valve interstitial cells (VICs) are commonly used, along with endothelial cells and animal models.
How does EDITGENE support aortic valve formation research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to study genes involved in aortic valve formation.
Conclusion
Aortic valve formation (GO:0003189) is a fundamental developmental process that establishes the structural foundation of the aortic valve. Research has uncovered critical roles for signaling pathways such as Notch, ERK1/2, JNK, and NF-kB, as well as transcription factors like RUNX2 and FOXO1, in both normal valve development and disease. Dysregulation of these pathways contributes to calcific aortic valve disease and bicuspid aortic valve disease, highlighting the clinical relevance of understanding early valve formation. CRISPR-based models and advanced omics technologies continue to drive discoveries in this field, offering hope for novel therapeutic strategies.
References
- 1. Jiang C et al.. 2024. FOXO1 regulates RUNX2 ubiquitination through SMURF2 in calcific aortic valve disease.. Redox Biol 73:103215 PMID: 38810422
- 2. Wang Y et al.. 2021. DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells.. Eur Heart J 42(30):2935-2951 PMID: 34179958
- 3. Rajamannan NM. 2011. Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation.. Cardiovasc Pathol 20(3):168-76 PMID: 21257323
- 4. Garoffolo G et al.. 2025. Reversion of aortic valve cells calcification by activation of Notch signalling via histone acetylation induction.. Signal Transduct Target Ther 10(1):311 PMID: 40962819
- 5. Guo C et al.. 2025. AMBP protects against aortic valve calcification by inhibiting ERK1/2 and JNK pathways mediated by FHL3.. Theranostics 15(10):4398-4415 PMID: 40225558
- 6. Wang S et al.. 2022. PALMD regulates aortic valve calcification via altered glycolysis and NF-κB-mediated inflammation.. J Biol Chem 298(5):101887 PMID: 35367413
- 7. Zhang B et al.. 2025. Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy to Slow Progression of Calcific Aortic Valve Stenosis: Preclinical and Randomized Clinical Trials to Assess Safety and Efficacy.. Circulation 151(13):913-930 PMID: 39989354
- 8. Jiang C et al.. 2025. Oxidized LDL-induced FOXS1 mediates cholesterol transport dysfunction and inflammasome activation to drive aortic valve calcification.. Cardiovasc Res 121(12):1941-1955 PMID: 40990096
